These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36001465)

  • 21. Nebulized Amikacin and Fosfomycin for Severe Pseudomonas aeruginosa Pneumonia: An Experimental Study.
    Li Bassi G; Motos A; Fernandez-Barat L; Aguilera Xiol E; Chiurazzi C; Senussi T; Saco MA; Fuster C; Carbonara M; Bobi J; Amaro R; De Rosa F; Comaru T; Yang H; Ranzani OT; Marti JD; Rinaudo M; Comino Trinidad O; Rigol M; Bringué J; Ramirez J; Nicolau DP; Pelosi P; Antonelli M; Blasi F; Artigas A; Montgomery AB; Torres A
    Crit Care Med; 2019 Jun; 47(6):e470-e477. PubMed ID: 30882478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant
    Yu L; Zhang J; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Li C; Zhang X
    Front Cell Infect Microbiol; 2019; 9():422. PubMed ID: 31921701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem, and Colistin Single and Binary Combinations Against Carbapenem Resistant Klebsiella pneumoniae Strains Isolated from Various Clinical Specimens].
    Köle M; Sesli Çetin E; Şirin MC; Cicioğlu Arıdoğan B
    Mikrobiyol Bul; 2022 Apr; 56(2):230-250. PubMed ID: 35477227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefquinome-Loaded Microsphere Formulations in Protection against Pneumonia with Klebsiella pneumonia Infection and Inflammatory Response in Rats.
    Qu S; Dai C; Yang F; Huang T; Hao Z; Tang Q; Wang H; Zhang Y
    Pharm Res; 2019 Mar; 36(5):74. PubMed ID: 30923922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inosine and D-Mannose Secreted by Drug-Resistant
    Zhang Y; Zhou Z; Xiao W; Tang Y; Guan W; Wang J; Shu F; Shen J; Gu S; Zhang L; Wang Q; Xie L
    Molecules; 2022 May; 27(9):. PubMed ID: 35566345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of tigecycline alone or in combination for experimental infections by KPC carbapenemase-producing Klebsiella pneumoniae.
    Fergadaki S; Renieris G; Machairas N; Sabracos L; Droggiti DI; Misiakos E; Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2021 Sep; 58(3):106384. PubMed ID: 34161789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asian sand dust enhances murine lung inflammation caused by Klebsiella pneumoniae.
    He M; Ichinose T; Yoshida S; Yamamoto S; Inoue K; Takano H; Yanagisawa R; Nishikawa M; Mori I; Sun G; Shibamoto T
    Toxicol Appl Pharmacol; 2012 Jan; 258(2):237-47. PubMed ID: 22118940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.
    Petraitiene R; Petraitis V; Kavaliauskas P; Maung BBW; Khan F; Naing E; Aung T; Zigmantaite V; Grigaleviciute R; Kucinskas A; Stakauskas R; Georgiades BN; Mazur CA; Hayden JA; Satlin MJ; Walsh TJ
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015048
    [No Abstract]   [Full Text] [Related]  

  • 29. Variation in the formation of persister cells against meropenem in Klebsiella pneumoniae bacteremia and analysis of its clinical features.
    Lee JS; Choi JY; Chung ES; Peck KR; Ko KS
    Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114853. PubMed ID: 31353067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of carbapenems alone and in combination with amikacin against KPC-producing Klebsiella pneumoniae.
    Le J; McKee B; Srisupha-Olarn W; Burgess DS
    J Clin Med Res; 2011 May; 3(3):106-10. PubMed ID: 21811540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.
    Hagihara M; Kato H; Sugano T; Okade H; Sato N; Shibata Y; Sakanashi D; Asai N; Koizumi Y; Suematsu H; Yamagishi Y; Mikamo H
    Int J Antimicrob Agents; 2021 May; 57(5):106330. PubMed ID: 33789129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice.
    Yang C; Lou W; Zhong G; Lee A; Leong J; Chin W; Ding B; Bao C; Tan JPK; Pu Q; Gao S; Xu L; Hsu LY; Wu M; Hedrick JL; Fan W; Yang YY
    Acta Biomater; 2019 Aug; 94():268-280. PubMed ID: 31129359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Amikacin and Meropenem on Colistin-Induced
    Vatansever C; Ozer B; Atac N; Guler OU; Kilicoglu BK; Berkkan M; Baskurt D; Sever E; Dogan O; Can F
    Microb Drug Resist; 2022 Jul; 28(7):765-772. PubMed ID: 35759379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of KPC Production and High-Level Meropenem Resistance on All-Cause Mortality of Ventilator-Associated Pneumonia in Association with Klebsiella pneumoniae.
    Rivera-Espinar F; Machuca I; Tejero R; Rodríguez J; Mula A; Marfil E; Cano Á; Gutiérrez-Gutiérrez B; Rodríguez M; Pozo JC; De la Fuente C; Rodriguez-Baño J; Martínez-Martínez L; León R; Torre-Cisneros J
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32205347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Host Defense against
    Rangasamy T; Ghimire L; Jin L; Le J; Periasamy S; Paudel S; Cai S; Jeyaseelan S
    J Immunol; 2021 Aug; 207(4):1112-1127. PubMed ID: 34341173
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro activity of polymyxin B in combination with meropenem, amikacin and gentamicin against Klebsiella pneumoniae clinical isolates co-harbouring aminoglycoside-modifying enzymes, bla
    Firmo EF; Oliveira Júnior JB; Scavuzzi AML; Alves LC; Brayner FA; Veras DL; Lopes ACS
    J Glob Antimicrob Resist; 2020 Sep; 22():511-514. PubMed ID: 32344124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-Frequency Ultrasound Enhances Antimicrobial Activity of Colistin-Vancomycin Combination against Pan-Resistant Biofilm of Acinetobacter baumannii.
    Liu X; Yin H; Weng CX; Cai Y
    Ultrasound Med Biol; 2016 Aug; 42(8):1968-75. PubMed ID: 27131840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of NF-κB/MAPK signaling pathway attenuates the acute lung inflammation in Klebsiella pneumonia rats by mollugin treatment.
    Zhang Y; Zhou S; Zhou J; Wang D; Zhou T
    Microb Pathog; 2019 Jul; 132():369-373. PubMed ID: 31075430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbapenem-resistant K. pneumoniae exhibiting clinically undetected amikacin and meropenem heteroresistance leads to treatment failure in a murine model of infection.
    Zhang F; Ding M; Yan X; Bai J; Li Q; Zhang B; Liang Q; Liang S; Wang G; Zhou Y
    Microb Pathog; 2021 Nov; 160():105162. PubMed ID: 34461245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.